Clonidine Hci Injection, Solution
Product Images NDC 51662-1346

This is a table comparing the adverse events experienced by patients who were given Clonidine versus those who were given a Placebo. The table shows that out of the total number of patients who experienced at least one adverse event, a higher percentage of patients who were given Clonidine experienced adverse events compared to those given Placebo. The highest adverse event experienced by patients on Clonidine was hypotension. Other adverse events experienced by patients on Clonidine include postural hypotension, dry mouth, nausea, somnolence, dizziness, confusion, vomiting, sweating, chest pain, hallucination, tinnitus, constipation, tachycardia, and hypoventilation.*

This document provides instructions for determining the final concentration of Clonidine Hydrochloride Injection by using 0.9% Sodium Chloride for Injection, resulting in different volume measurements ranging from 1mL to 50mL. The concentration of Clonidine Hydrochloride Injection varies from 500 micrograms/mL to 5000 micrograms/50 mL.*

Clonidine is a medication used to treat high blood pressure. It works by decreasing the levels of certain chemicals in the blood, which results in the relaxation of the blood vessels and a decrease in heart rate. Clonidine may also be used to treat ADHD and anxiety disorders. It is usually taken orally in tablet form or applied as a patch to the skin. Common side effects of clonidine include dry mouth, dizziness, drowsiness, and constipation.*

The 500 mcg/mL strength product should be diluted prior to use in an appropriate solution.*

Clonidine hydrochloride injection (epidural clonidine) is not recommended for obstetrical, postpartum, or peri-operative pain management. The risk of hemodynamic instability, especially hypotension and bradycardia, from epidural clonidine may be unacceptable in these patients. However, in a rare obstetrical, post-partum or peri-operative patient, potential benefits may outweigh the possible risks.*

CsHsCENxHCI is a chemical compound with a molecular weight of 266.56.*

This is a description of Clonidine HCI injection which contains 100mg of Clonidine Hydrochloride, USP and 5mg of Sodium Chloride, USP in Water for Injection, USP. The solution is preservative-free and has pH adjusted with HCI and/or NaOH. The usual dosage is available in a package insert. The solution should be stored at 25°C (77°F), and the excursions are permitted to 15% to 30°C (59° to 86°F). The solution is sterile and non-pyrogenic, and the manufacturer is ROAA Farmaceutica Portugal, SA, and distributed by West Ward Pharmaceutical Corp., Extonown, 07724, USA.*